Sean P Dineen Selected Research

Sean P Dineen Research Topics

Disease

24	Neoplasms (Cancer) 12/2023 - 06/2008
10	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2008
6	Peritoneal Neoplasms 03/2024 - 01/2016
5	Adenocarcinoma 01/2022 - 09/2016
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2008
4	Stomach Neoplasms (Stomach Cancer) 03/2024 - 08/2021
4	Colonic Neoplasms (Colon Cancer) 02/2024 - 07/2019
4	Mesothelioma 08/2021 - 08/2013
3	Appendiceal Neoplasms (Appendix Cancer) 09/2023 - 12/2020
3	Breast Neoplasms (Breast Cancer) 07/2010 - 07/2009
2	Pulmonary Embolism 01/2022 - 08/2021
2	Hemorrhage 08/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2016
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2020 - 10/2015
1	Disease Progression 02/2024
1	HIV Infections (HIV Infection) 10/2022
1	Pleural Effusion (Pleural Effusions) 08/2021
1	Fistula 08/2021
1	Ovarian Neoplasms (Ovarian Cancer) 08/2021
1	Venous Thromboembolism 01/2017
1	Thrombophilia 01/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Thrombosis (Thrombus) 09/2015
1	Intraoperative Complications 06/2015
1	Surgical Wound Infection 06/2015
1	Ischemia 12/2010
1	Endometrial Neoplasms (Endometrial Cancer) 07/2010
1	Hyperplasia 07/2010
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2009

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 06/2008
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2009 - 06/2008
2	SPAAT inhibitorIBA 01/2020 - 10/2015
2	Gemcitabine FDA Link 04/2010 - 11/2008
2	CytokinesIBA 11/2009 - 06/2008
2	Bevacizumab (Avastin)FDA Link 07/2009 - 05/2009
1	catch-relaxing peptide (Mytilus)IBA 02/2024
1	Tumor Biomarkers (Tumor Markers)IBA 02/2024
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	CyclinsIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	CateninsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	propionyl-alpha-bungarotoxin (PABT)IBA 08/2021
1	Cyclin D1IBA 01/2016
1	Axl Receptor Tyrosine KinaseIBA 09/2015
1	Vitamin K FDA Link 09/2015
1	Warfarin (Coumadin)FDA LinkGeneric 09/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 06/2015
1	AsbestosIBA 08/2013
1	matrigelIBA 12/2010
1	Estrogen Receptor alphaIBA 07/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2010
1	GTP-Binding Proteins (G-Protein)IBA 07/2010
1	LigandsIBA 02/2010
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010
1	DecorinIBA 01/2010
1	CollagenIBA 01/2010
1	Cysteine (L-Cysteine)FDA Link 01/2010
1	Fibrillar CollagensIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Proteoglycans (Proteoglycan)IBA 01/2010
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Interleukin-6 (Interleukin 6)IBA 11/2009
1	Immunoglobulin G (IgG)IBA 07/2009
1	Monoclonal AntibodiesIBA 07/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2009
1	CT-322IBA 11/2008
1	pleiotrophin (HARP)IBA 06/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2008

Therapy/Procedure

19	Hyperthermic Intraperitoneal Chemotherapy 03/2024 - 10/2015
14	Cytoreduction Surgical Procedures 02/2024 - 01/2016
8	Therapeutics 06/2023 - 11/2008
7	Drug Therapy (Chemotherapy) 06/2023 - 07/2009
3	Gastrectomy 06/2023 - 01/2020
2	Length of Stay 03/2024 - 08/2021
2	Operative Time 01/2022 - 06/2015
2	Neoadjuvant Therapy 10/2021 - 03/2020
2	Adjuvant Chemotherapy 06/2021 - 01/2021
1	Esophagectomy 01/2022
1	Pancreaticoduodenectomy 01/2017
1	Chemoprevention 01/2017
1	Radiotherapy 11/2015
1	Transplantation 12/2010
1	Blood Transfusion (Blood Transfusions) 05/2009